Precision BioSciences, Inc., a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies with its ARCUS® genome editing platform, announced that Alex Kelly has been appointed to the newly created position of Chief Corporate Affairs Officer.
October 14, 2020
· 3 min read